Karafin MS - Search Results

1

Patient factors associated with unidentified reactivity in solid-phase and polyethylene glycol antibody detection methods.

Miller NM, Johnson ST, Carpenter E, Naczek CA, Karafin MS. Miller NM, et al. Among authors: karafin ms. Transfusion. 2017 May;57(5):1288-1293. doi: 10.1111/trf.14079. Epub 2017 Mar 14. Transfusion. 2017. PMID: 28294343

2

ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions.

Karafin MS, Blagg L, Tobian AA, King KE, Ness PM, Savage WJ. Karafin MS, et al. Transfusion. 2012 Oct;52(10):2087-93. doi: 10.1111/j.1537-2995.2012.03574.x. Epub 2012 Feb 17. Transfusion. 2012. PMID: 22339320 Free PMC article.

3

Transfusion medicine education: an integral foundation of effective blood management.

Karafin MS, Bryant BJ. Karafin MS, et al. Transfusion. 2014 May;54(5):1208-11. doi: 10.1111/trf.12658. Transfusion. 2014. PMID: 24819073 No abstract available.

4

The future of red blood cell alloimmunization risk reduction.

Karafin MS, Denomme GA, Bryant BJ. Karafin MS, et al. Transfusion. 2015 Jan;55(1):220-1. doi: 10.1111/trf.12863. Transfusion. 2015. PMID: 25582238 No abstract available.

5

Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease.

Karafin MS, Field JJ, Gottschall JL, Denomme GA. Karafin MS, et al. Transfusion. 2015 Jun;55(6 Pt 2):1399-406. doi: 10.1111/trf.13037. Epub 2015 Mar 9. Transfusion. 2015. PMID: 25757390

6

Red cell storage age policy for patients with sickle cell disease: A survey of transfusion service directors in the United States.

Karafin MS, Singavi AK, Irani MS, Puca KE, Baumann Kreuziger L, Simpson P, Field JJ. Karafin MS, et al. Transfus Apher Sci. 2016 Feb;54(1):158-62. doi: 10.1016/j.transci.2015.12.001. Epub 2015 Dec 23. Transfus Apher Sci. 2016. PMID: 26775259

7

Trends in US minority red blood cell unit donations.

Yazer MH, Delaney M, Germain M, Karafin MS, Sayers M, Vassallo R, Ziman A, Shaz B; Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Yazer MH, et al. Among authors: karafin ms. Transfusion. 2017 May;57(5):1226-1234. doi: 10.1111/trf.14039. Epub 2017 Feb 16. Transfusion. 2017. PMID: 28205236

8

Older red cell units are associated with an increased incidence of infection in chronically transfused adults with sickle cell disease.

Karafin MS, Carpenter E, Pan A, Simpson P, Field JJ. Karafin MS, et al. Transfus Apher Sci. 2017 Jun;56(3):345-351. doi: 10.1016/j.transci.2017.01.008. Epub 2017 Feb 9. Transfus Apher Sci. 2017. PMID: 28279592

9

A Fatal Case of Immune Hyperhemolysis with Bone Marrow Necrosis in a Patient with Sickle Cell Disease.

Karafin MS, Singavi A, Johnson ST, Field JJ. Karafin MS, et al. Hematol Rep. 2017 Mar 1;9(1):6934. doi: 10.4081/hr.2017.6934. eCollection 2017 Feb 23. Hematol Rep. 2017. PMID: 28286630 Free PMC article.

10

Trends in age and red blood cell donation habits among several racial/ethnic minority groups in the United States.

Yazer MH, Vassallo R, Delaney M, Germain M, Karafin MS, Sayers M, van de Watering L, Shaz BH; Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Yazer MH, et al. Among authors: karafin ms. Transfusion. 2017 Jul;57(7):1644-1655. doi: 10.1111/trf.14108. Epub 2017 Mar 28. Transfusion. 2017. PMID: 28370164

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters